View Press Releases
-
CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products
-
Drug Discovery: Combining the Power of Computational Chemistry with Multiple Applications
-
Alfa Chemistry Now Becomes A High-Quality 2D Material Supplier
-
CCDC Welcomes New Applications for its FAIRE Grants to Advance Structural Science
FAIRE grants provide access to the Cambridge Structural Database, software and training. The Frank H. Allen International Research & Education Programme (FAIRE) provides long-term grants to enable academic research in structural chemistry in over 80 eligible countries. Launched in 2017, the number of research and educational institutions with a FAIRE license nearly doubled in 2022 to 31. The initiative has supported researchers to publish over 100 scientific publications in primary research journals since its launch. With research and education organisations in over 80 countries eligible to apply, the FAIRE programme has the potential to greatly widen its positive impact and new applications are welcomed. Continued engagement with the structural science community through conferences like the Pan African Conference on Crystallography (PCCr3) currently being held in Nairobi, Kenya, aims to grow and further support the FAIRE community.
Jan 15, 2023
-
With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand
With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand
Jan 11, 2023
-
Thermo Fisher Scientific Joins Momentum Labs as Founding Sponsor of New Biotech Hub in Alachua, Florida
-
Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future
-
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment
Jan 9, 2023
-
CSafe Further Expands Its Digital Ecosystem with Enhancement of CSafe Connect and Launch of TracSafe Data Logger Suite
CSafe Connect enables a truly connected supply chain by bringing together product ordering, shipment analytics and customer support under a single login
Jan 9, 2023
-
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark
Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.
Jan 9, 2023
-
SANGUINE BIOSCIENCES PARTNERS WITH BROADOAK CAPITAL PARTNERS TO ACCELERATE LAUNCH OF NEW PRODUCTS AND SERVICES IN SUPPORT OF CELL & GENE THERAPY MARKETS
Investment will support ongoing partnerships with apheresis clinics, expansion of laboratory services, enhancement of patient data aggregation, and amplification of Sanguine’s network of 60,000+ research-ready patient donor network.
Jan 8, 2023
-
Quanticate makes key appointment to bolster leadership team
-
ODAIA Appoints Former WebMD Exec Dr. Eric Trépanier as Chief Commercial Officer
-
OncoDxRx’s Breakthrough Technology Advances Gene-Drug Matching
OncoDxRx's PGA technology is the world-first test that enables gene-drug matching for optimal treatment regimen from hundreds of anti-cancer drugs based on patients’ own gene expression profiles
Jan 7, 2023
-
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke
Jan 5, 2023
-
Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team
Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team
Jan 1, 2023
-
Molecular Devices and Advanced Solutions Life Sciences collaborate to develop 3D Biology Automation Technologies for Drug Discovery
Molecular Devices, a leader in high-performance life sciences solutions, on Wednesday announced a new collaboration with Advanced Solutions, a biofabrication and life sciences robotics company. This new collaboration takes the form of a turnkey solution that systematically bioprints organoids in a fully-automated enclosure, with award-winning high-content imaging capabilities that inform the modeling and screening process for increased precision--enabling the industry to grow, screen, and analyze high-quality, viable, 3D cell cultures at scale.
Jan 3, 2023
-
CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies
CD BioSciences recently launched another comprehensive panel of research solutions for autophagic cell death studies.
Jan 4, 2023
-
Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services
Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.
Jan 4, 2023
-
STEMart Introduces API Impurity Identification Services for Medical Devices
STEMart has recently introduced API Impurity Identification services for global clients.
Jan 4, 2023